
The first major rewrite since 2015 sorts therapies by mechanism of action, splits care into reactive and proactive phases, and adds guidance on 2 newer Janus kinase (JAK) inhibitors.
Check out this week's highlights.
As July comes to a close and we enter the final full month of summer, we will continue to deliver timely and engaging veterinary news and industry hot topics right to your fingertips.
Discover this week's highlights:
Stay tuned on social media and dvm360.com for more veterinary news.






